Survival in Patients With Presymptomatic Diagnosis of Metastatic Uveal Melanoma
Authors:
- Ivana K. KimIKIvana K. Kim
- Anne Marie LaneALAnne Marie Lane
- Evangelos S. GragoudasEGEvangelos S. Gragoudas
Open Access
- 1 July 2010
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 128 (7) , 871-875
Abstract
Despite excellent rates of local control of primary intraocular tumor, metastatic disease remains the leading cause of death in patients with uveal melanoma.1 Prior investigations of metastasis after proton beam irradiation for uveal melanoma revealed that the cumulative probability of metastasis at 5 years after primary treatment was 20%, with a median time to metastasis of 2.1 years after treatment.2Similarly, cumulative rates of metastasis in the Collaborative Ocular Melanoma Study3 at 5 years and 10 years after treatment were 25% and 34%, respectively. Once metastases develop, median survival is short, typically less than 1 year.4,5 The site and extent of metastases affect length of survival. Patients in whom metastases are confined to extrahepatic locations have significantly longer survival (median, 19-28 months).6 However, most patients who develop metastases have liver involvement, which results in 1-year survival of approximately 10% to 15%.6Keywords
This publication has 10 references indexed in Scilit:
- Effectiveness of Treatments for Metastatic Uveal MelanomaAmerican Journal of Ophthalmology, 2009
- Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal MelanomaClinical Cancer Research, 2007
- Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patientsAnnals of Oncology, 2006
- Variates of Survival in Metastatic Uveal MelanomaJournal of Clinical Oncology, 2005
- Prognostic factors of liver metastases from uveal melanomaGraefe's Archive for Clinical and Experimental Ophthalmology, 2005
- Treatment of Liver Metastases From Uveal MelanomaAnnals of Surgical Oncology, 2005
- Very Long-Term Prognosis of Patients with Malignant Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2003
- A prognostic model and staging for metastatic uveal melanomaCancer, 2003
- Protracted survival after resection of metastatic uveal melanomaCancer, 2000
- Treatment of liver metastases from uveal melanoma by combined surgery—chemotherapyEuropean Journal of Surgical Oncology, 1998